Atlas Trials

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

Clinical trial NCT03636438 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03636438
Sponsor
Ultragenyx Pharmaceutical Inc
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Ornithine Transcarbamylase (OTC) Deficiency
Start date
2018-08-30
Primary completion
2029-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.